JENNIFER CASCHETTA: Open Payments
NPI 1225735947 · OKEECHOBEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 21 payments from 8 companies in 2025. Trend: 2023 $391 · 2024 $197 · 2025 $886
Food & beverage: $886
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $287 |
| Janssen Pharmaceuticals, Inc | 4 | $227 |
| Vanda Pharmaceuticals Inc. | 3 | $168 |
| Teva Pharmaceuticals USA, Inc. | 3 | $74 |
| Alkermes, Inc. | 3 | $56 |
| Lundbeck LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: VRAYLAR, INVEGA SUSTENNA, FANAPT, AUSTEDO XR, SPRAVATO, ARISTADA, REXULTI, CAPLYTA.
Industry payments across FL — which companies pay providers there.
